Biosafety: Institutional Biosafety Council (IBC)

The Institutional Biosafety Council (IBC) will review research involving the use of recombinant DNA molecules to ensure it is conducted safely and in compliance with guidelines established by the National Institutes of Health and the Center for Disease Control. The IBC will assure the safety of the research for the university and general community by providing outreach, education and support for principal investigators and their staff.

Generally, the term recombinant DNA refers to novel "unnatural" DNA molecules that are engineered by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell. The possibility for novel life forms of unknown toxicity or environmental hazard has been a concern since rDNA technology was invented in 1973. For these reasons, rDNA is considered a potential biohazard, and NIH has mandated that research institutions monitor and regulate its use.

IBC Contact Information


Director of Research Protections
Robin Tyndall

Assistant Director of Research Protections
Monica Molina

Assistant Director of IACUC and IBC Programs
Shante' Mathes

Compliance Coordinator
Dennis Gabriels

QEP Global Learning